ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 997–1008 of 2020 project topics
Real-Time Biomarker Monitoring Analytics Dashboard for Active Trials
A monitoring service that tracks genetic and protein biomarker performance metrics throughout trial execution with automated alerts for safety signals and efficacy endpoints. This delivers immediate ROI by preventing failed trials, enabling mid-course corrections, and supporting accelerated regulatory pathways worth millions in time savings.
Genetic Biomarkers in Clinical Trials Click to view more details →
Biomarker Assay Validation and Certification as a Service
A specialized service offering that conducts comprehensive analytical and clinical validation of genetic biomarker assays to meet FDA, EMA, and ICH guidelines for trial submission. This positions service providers as critical partners in the biomarker-driven drug development ecosystem, generating recurring revenue from validation contracts and IP licensing.
Genetic Biomarkers in Clinical Trials Click to view more details →
Genetic Biomarker Predictive Modeling for Phase Transition Planning
A software tool that uses historical biomarker data and statistical modeling to forecast trial outcomes and optimize progression criteria between Phase II and Phase III studies. This reduces development risk and capital expenditure for sponsors while improving the probability of regulatory approval, creating competitive advantage in deal-making.
Genetic Biomarkers in Clinical Trials Click to view more details →
Biomarker Data Marketplace for Cross-Trial Comparative Effectiveness Research
A secure, federated data platform that enables pharmaceutical companies and research institutions to share de-identified biomarker datasets across multiple trials while maintaining privacy and IP protection. This generates new revenue streams through data licensing, real-world evidence analytics, and accelerates time-to-insight for drug developers and diagnostic companies.
Genetic Biomarkers in Clinical Trials Click to view more details →
SCN9A Channelopathy Genetic Diagnosis
Characterizing gain-of-function SCN9A variants causing inherited erythromelalgia and paroxysmal extreme pain disorder for molecular diagnosis.
Genetic Basis of Pain Disorders Click to view more details →
Congenital Insensitivity to Pain Gene Testing
Identifying SCN9A loss-of-function, NTRK1, and PRDM12 variants causing congenital insensitivity to pain for molecular diagnosis in affected children.
Genetic Basis of Pain Disorders Click to view more details →
Fabry Disease GLA Variant Characterization
Characterizing GLA pathogenic and non-pathogenic variants causing Fabry disease for accurate diagnosis and distinguishing from normal variants.
Genetic Basis of Pain Disorders Click to view more details →
Familial Hemiplegic Migraine Gene Analysis
Testing ATP1A2, CACNA1A, and SCN1A variants causing familial hemiplegic migraine for molecular subtype diagnosis and treatment guidance.
Genetic Basis of Pain Disorders Click to view more details →
TRPV1 Polymorphism Phenotyping SaaS Platform
A cloud-based diagnostic platform that maps TRPV1 genetic variants to individual pain sensitivity profiles using machine learning algorithms. This enables pharmaceutical companies to stratify patient populations for targeted analgesic drug development and personalized pain management protocols.
Genetic Basis of Pain Disorders Click to view more details →
Neuropathic Pain Susceptibility Gene Panel Service
A commercial genetic testing service that screens multiple pain-related genes including OPRM1, COMT, and GCH1 to predict neuropathic pain risk and opioid response variability. Healthcare providers and insurers use this service to optimize treatment selection and reduce adverse drug events, improving patient outcomes and reducing operational costs.
Genetic Basis of Pain Disorders Click to view more details →
Migraine Genetic Risk Stratification Analytics Tool
An integrated bioinformatics tool that analyzes CACNA1A, ATP1A2, and SCN1A variants to classify migraine patients into clinical risk tiers for preventive therapy selection. This platform helps neurologists and health systems implement precision medicine protocols that improve treatment efficacy rates and reduce emergency department utilization.
Genetic Basis of Pain Disorders Click to view more details →
Complex Regional Pain Syndrome Genomic Screening Kit
A direct-to-consumer genetic test kit that identifies predisposing variants in immune and inflammatory response genes associated with CRPS susceptibility and severity. The commercial model generates recurring revenue through clinical interpretation reports, genetic counseling services, and partnerships with pain management clinics.
Genetic Basis of Pain Disorders Click to view more details →